Vaccine stabilizer containing L-glutamic acid and L-arginine
US4338335A · kind A · utility
36Cited by
13References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 30, 1980 |
| Grant date | Jul 6, 1982 |
| Priority date | — |
| Expiry date | Jul 30, 2000 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An improved stabilized liquid live viral vaccine contains a live virus, partially hydrolyzed gelatin, a monosaccharide or disaccharide, a cell culture medium, L-glutamic acid, L-arginine and sufficient physiologically acceptable acidic buffer to maintain the pH at from about 6.0 to about 6.5.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.